Clowes Howard

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$65,633.33
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Clowes Howard

According to the SEC Form 4 filings, Clowes Howard, being in a position of

  1. director at Plus Therapeutics, Inc.,
    оver the last 12 months, has bought 14804 shares for $26,681, and sold 0 shares,
    over all time since 2021-03-03, has bought 43297 shares for $65,633, and sold 0 shares.

The largest purchase of all time was on 2024-05-08 and amounted to 9804 shares of Plus Therapeutics, Inc. for $20,000.

Biography of Clowes Howard

No biography is available at this moment.

2024-09-11PurchasePlus Therapeutics, Inc.
PSTV
director
5,000
0.0899%
$1.34$6,6810%
2024-05-08PurchasePlus Therapeutics, Inc.
PSTV
director
9,804
0.206%
$2.04$20,000-29.74%
2023-09-13PurchasePlus Therapeutics, Inc.
PSTV
director
6,993
0.2417%
$1.43$10,022+26.57%
2023-06-06PurchasePlus Therapeutics, Inc.
PSTV
director
1,000
0.003%
$3.98$3,980-48.4%
2023-05-03PurchasePlus Therapeutics, Inc.
PSTV
director
2,500
0.007%
$3.64$9,102-48.27%
2022-06-02PurchasePlus Therapeutics, Inc.
PSTV
15,000
0.0046%
$0.57$8,589-23.21%
2021-03-03PurchasePlus Therapeutics, Inc.
PSTV
director
3,000
0.0024%
$2.42$7,260-20%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.